QHSLab, Inc. (USAQ)
OTCMKTS · Delayed Price · Currency is USD
0.1900
0.00 (0.00%)
Aug 26, 2025, 8:00 PM EDT
QHSLab Market Cap
QHSLab has a market cap or net worth of $2.14 million as of August 28, 2025. Its market cap has increased by 878.54% in one year.
Market Cap
2.14M
Enterprise Value
3.57M
Revenue
2.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since March 1, 1995, QHSLab's market cap has decreased from 23.47M to 2.14M, a decrease of -90.87%. That is a compound annual growth rate of -7.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 2.14M | -18.41% |
| Dec 31, 2024 | 2.63M | 199.84% |
| Dec 26, 2023 | 876.20K | -42.65% |
| Dec 30, 2022 | 1.53M | -76.10% |
| Dec 31, 2021 | 6.39M | 110.36% |
| Dec 31, 2020 | 3.04M | 1,666.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 594.22M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |